Outcomes of Allogeneic Haemopoietic Transplant for Chronic Lymphocytic Leukaemia in the Modern Era

Scientists examined the use of HSCT performed for chronic lymphocytic leukaemia in Australia and New Zealand, including patients exposed to pathway inhibitors prior to transplant.